These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28586030)

  • 1. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
    Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Sulik M; Kmiec Z
    Oncol Rep; 2017 Jul; 38(1):201-210. PubMed ID: 28586030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and Prognostic Significance of
    Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwińska-Jewsiewicka A; Wierzbicki PW; Kmieć Z
    Anticancer Res; 2017 Jun; 37(6):2927-2937. PubMed ID: 28551630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
    Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
    Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
    Yuan H; Tu SL; He XJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
    Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
    Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
    Peng L; Wang R; Shang J; Xiong Y; Fu Z
    Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.
    Zeng J; Tang ZH; Liu S; Guo SS
    World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
    Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
    J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p16INK4a, alone or combined with p53, is predictive of better prognosis in colorectal adenocarcinoma in Tunisian patients.
    Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Amouri A; Frikha F; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):562-8. PubMed ID: 22095233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-expression pattern of Ku70 and p53 coexisted in colorectal cancer.
    Lu Y; Gao J; Lu Y
    Med Oncol; 2015 Apr; 32(4):98. PubMed ID: 25731619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
    Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
    Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.